Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1979-08-14
1987-09-01
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514363, 514255, 514308, 514423, 548531, 548535, 546310, A61K 3140, A61K 3141, C07D20700, C07D21172
Patent
active
046909400
ABSTRACT:
Novel Compounds are disclosed as potent inhibitors of angiotensin converting enzyme and as orally effective antihypertensive agents. The compounds have the general formula: ##STR1##
REFERENCES:
patent: 3832337 (1974-08-01), Ondetti
patent: 3891616 (1975-06-01), Ondetti
patent: 3947575 (1976-03-01), Ondetti
patent: 4046889 (1977-09-01), Ondetti
patent: 4052511 (1977-10-01), Cushman
patent: 4053651 (1977-10-01), Ondetti
patent: 4070361 (1978-01-01), Petrillo
patent: 4091024 (1978-05-01), Ondetti
patent: 4105776 (1978-08-01), Ondetti
patent: 4105789 (1978-08-01), Ondetti
patent: 4108886 (1978-08-01), Ondetti
patent: 4113715 (1978-09-01), Ondetti
patent: 4116962 (1978-09-01), Ondetti
patent: 4129566 (1978-12-01), Ondetti
patent: 4146611 (1979-03-01), Ondetti
patent: 4151172 (1979-04-01), Ondetti
patent: 4154840 (1979-05-01), Ondetti
patent: 4154934 (1979-05-01), Bernstein
patent: 4154935 (1979-05-01), Ondetti
patent: 4154937 (1979-05-01), Cushman
patent: 4168267 (1979-09-01), Petrillo
Cronyn, et al., J. Am. Chem. Soc., 74:4726 (1952).
Fischer et al., Ber, 33:2383 (1900).
Fisher et al., FEBS Letters, 107:273 (1979).
Lehninger A. Biochemistry, pp. 189-194 (1975).
Ryan, J. W., et al., Biochem.J. 167:501 (1977).
Methoden der Organischen Chem (Houben-Weyl), vol. XV, p. 1, p. 376 et seq. (1974).
Methoden der Organischen Chem (Houben-Weyl), vol. XV, pt. II, p. 1 et seq. (1974).
Carter et al., J. Biol. Chem, 138:627 (1941).
Engel, et al., Proc. Soc. Exp. Biol. Med., 143:483 (1973).
Jager et al., Chem. Ber. 103, 1727 (1970).
Klosterman et al., Biochem 6, 170 (1967).
Lijinski et al., Tetrahedron 26, 5137 (1970).
Nagasawa et al., J. Med. Chem. 16, 583 (1973).
Mita et al., Chem. Pharm. Bull. 26 (4), 1333-1335 (1978).
Kripalani et al., Clin Pharmacol. Ther. 27 (5), 636-641 (1980).
Pfister et al., J. Am. Chem. Soc. 71, 1096 (1949).
Merrifield, Adv Enzymol 32, 221 (1969).
Ricci et al., Anal Biochem. 79, 610 (1977).
Cushman, D. W. et al., Progr. Cardiovasc. Dis. 21, 176 (1978).
Oparil et al., Circ. Res. 32, 415 (1973).
Oparil et al., Circ. Res. 29, 682 (1971).
Dorer et al., Biochem J. 141, 915 (1974).
Sharpless, S. K., "Hypnotics and Sedatives", The Pharmacological Basis of Therapeutics, The Macmillan Co., (1965), pp. 105-128.
Kripalani, K. J. et al., Abstracts, Joint Meeting of ASPET/SOT, Aug. 13-17, 1978.
Singhvi, S. M. et al., Abstracts, Joint Meeting of ASPET/SOT, Aug. 13-17, 1978.
Wong, K. K. and Dreyfuss, J., Abstracts, Joint Meeting of ASPET/SOT, Aug. 13-17, 1978.
Buxton et al., J. Chem. Soc., p. 366 (1954).
Lehninger, Biochemistry, Worth Pub. NY, 1970, pp. 153-157.
Ryan et al., Tissue & Cell, vol. 10, 1978, p. 555.
Cushman et al., Biochemistry, vol. 16, 1977, p. 5484.
Cushman et al., Experientia, vol. 29, 1973, p. 1032.
Ondetti et al., Science, vol. 196, 1977, p. 441.
Dorer et al., Biochem. Biophys. Acta., vol. 429, 1976, p. 220.
Fisher et al., Arch. Biochem. Biophys., vol. 189, 1978, p. 81.
Gavras et al., N.E. J. Med, vol. 291, 1974, p. 817.
Gavras et al., NE J Med, vol. 298, 1978, p. 991.
Lipmann, Accounts Chem Res., vol. 6, 1973, p. 6.
Chung Alfred
Ryan James W.
Phillips Delbert R.
University of Miami
LandOfFree
Anti-hypertensive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-hypertensive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-hypertensive agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1265151